HEADER TRANSFERASE/TRANSFERASE INHIBITOR 10-AUG-10 3OCT TITLE CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE MUTANT V555R IN COMPLEX TITLE 2 WITH DASATINIB COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: BRUTON TYROSINE KINASE, AGAMMAGLOBULINAEMIA TYROSINE KINASE, COMPND 5 ATK, B-CELL PROGENITOR KINASE, BPK; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BTK, AGMX1, ATK, BPK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PBACGUS KEYWDS TYROSINE KINASE, TRANSFERASE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR D.R.DAVIES,B.L.STAKER REVDAT 3 06-SEP-23 3OCT 1 REMARK SEQADV REVDAT 2 17-NOV-10 3OCT 1 HEADER REVDAT 1 03-NOV-10 3OCT 0 JRNL AUTH J.A.DI PAOLO,T.HUANG,M.BALAZS,J.BARBOSA,K.H.BARCK, JRNL AUTH 2 R.A.D.CARANO,J.DARROW,D.R.DAVIES,L.E.DEFORGE,G.DENNIS JR., JRNL AUTH 3 L.DIEHL,R.FERRANDO JRNL TITL A NOVEL, SPECIFIC BTK INHIBITOR ANTAGONIZES BCR AND JRNL TITL 2 FC[GAMMA]R SIGNALING AND SUPPRESSES INFLAMMATORY ARTHRITIS JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0109 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 59.55 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 18379 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.199 REMARK 3 R VALUE (WORKING SET) : 0.196 REMARK 3 FREE R VALUE : 0.251 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.300 REMARK 3 FREE R VALUE TEST SET COUNT : 973 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1333 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.44 REMARK 3 BIN R VALUE (WORKING SET) : 0.2700 REMARK 3 BIN FREE R VALUE SET COUNT : 68 REMARK 3 BIN FREE R VALUE : 0.3300 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1992 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 33 REMARK 3 SOLVENT ATOMS : 101 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.92 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.40000 REMARK 3 B22 (A**2) : -0.99000 REMARK 3 B33 (A**2) : 0.79000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.86000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.198 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.181 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.127 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.689 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.951 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.913 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2093 ; 0.015 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2825 ; 1.543 ; 1.980 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 242 ; 6.443 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 96 ;34.501 ;23.750 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 374 ;14.960 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 12 ;16.764 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 296 ; 0.102 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1582 ; 0.006 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1222 ; 0.742 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1968 ; 1.401 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 871 ; 2.368 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 856 ; 3.649 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 2 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 394 A 475 REMARK 3 ORIGIN FOR THE GROUP (A): 18.4965 6.5333 14.9024 REMARK 3 T TENSOR REMARK 3 T11: 0.0281 T22: 0.0453 REMARK 3 T33: 0.0758 T12: -0.0111 REMARK 3 T13: -0.0033 T23: -0.0124 REMARK 3 L TENSOR REMARK 3 L11: 3.8068 L22: 1.6741 REMARK 3 L33: 2.2081 L12: 0.5350 REMARK 3 L13: 0.4949 L23: 0.3311 REMARK 3 S TENSOR REMARK 3 S11: 0.1452 S12: 0.0690 S13: -0.0727 REMARK 3 S21: 0.0699 S22: 0.0125 S23: -0.2960 REMARK 3 S31: 0.0492 S32: 0.2452 S33: -0.1577 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 476 A 656 REMARK 3 ORIGIN FOR THE GROUP (A): -6.7465 -1.0733 17.5630 REMARK 3 T TENSOR REMARK 3 T11: 0.0366 T22: 0.0164 REMARK 3 T33: 0.0156 T12: 0.0093 REMARK 3 T13: 0.0005 T23: 0.0078 REMARK 3 L TENSOR REMARK 3 L11: 1.0483 L22: 0.9324 REMARK 3 L33: 1.2483 L12: 0.3352 REMARK 3 L13: -0.1945 L23: 0.2557 REMARK 3 S TENSOR REMARK 3 S11: -0.0163 S12: 0.0879 S13: 0.0704 REMARK 3 S21: 0.0302 S22: -0.0168 S23: 0.0632 REMARK 3 S31: 0.0624 S32: -0.0102 S33: 0.0331 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 4 REMARK 4 3OCT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 24-AUG-10. REMARK 100 THE DEPOSITION ID IS D_1000060953. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-FEB-08 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 5.40 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 24-ID-C REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : NULL REMARK 200 WAVELENGTH OR RANGE (A) : 0.98 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22490 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.760 REMARK 200 RESOLUTION RANGE LOW (A) : 59.550 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 81.5 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.76 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.82 REMARK 200 COMPLETENESS FOR SHELL (%) : 51.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.20 REMARK 200 R MERGE FOR SHELL (I) : 0.36400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 3OCS REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.58 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.18 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM MES, PH 5.4, 20% PEG 3500, 200 REMARK 280 MM NACL, 3% POLYPROPYLENE GLYCOL P 400, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 289K, VAPOR DIFFUSION, SITTING DROP, PH 5.40 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 21.47200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 392 REMARK 465 GLY A 393 REMARK 465 GLY A 409 REMARK 465 THR A 410 REMARK 465 GLU A 434 REMARK 465 GLY A 435 REMARK 465 SER A 436 REMARK 465 TYR A 545 REMARK 465 VAL A 546 REMARK 465 LEU A 547 REMARK 465 ASP A 548 REMARK 465 ASP A 549 REMARK 465 GLU A 550 REMARK 465 TYR A 551 REMARK 465 THR A 552 REMARK 465 SER A 553 REMARK 465 SER A 554 REMARK 465 ARG A 555 REMARK 465 GLY A 556 REMARK 465 SER A 557 REMARK 465 LYS A 558 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 407 CG CD OE1 OE2 REMARK 470 LYS A 433 CG CD CE NZ REMARK 470 LYS A 466 CG CD CE NZ REMARK 470 GLN A 467 CG CD OE1 NE2 REMARK 470 ARG A 520 CG CD NE CZ NH1 NH2 REMARK 470 PHE A 559 CG CD1 CD2 CE1 CE2 CZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 513 CB GLU A 513 CG 0.121 REMARK 500 GLU A 513 CG GLU A 513 CD 0.113 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 520 -13.36 67.57 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 1N1 A 663 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3OCS RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF BRUTON'S TYROSINE KINASE IN COMPLEX WITH REMARK 900 INHIBITOR CGI1746 DBREF 3OCT A 393 656 UNP Q06187 BTK_HUMAN 393 656 SEQADV 3OCT GLY A 392 UNP Q06187 EXPRESSION TAG SEQADV 3OCT ARG A 555 UNP Q06187 VAL 555 ENGINEERED MUTATION SEQRES 1 A 265 GLY GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR PHE SEQRES 2 A 265 LEU LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL LYS SEQRES 3 A 265 TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE LYS SEQRES 4 A 265 MET ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE ILE SEQRES 5 A 265 GLU GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU LYS SEQRES 6 A 265 LEU VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG PRO SEQRES 7 A 265 ILE PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS LEU SEQRES 8 A 265 LEU ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN THR SEQRES 9 A 265 GLN GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU ALA SEQRES 10 A 265 MET GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG ASP SEQRES 11 A 265 LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY VAL SEQRES 12 A 265 VAL LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL LEU SEQRES 13 A 265 ASP ASP GLU TYR THR SER SER ARG GLY SER LYS PHE PRO SEQRES 14 A 265 VAL ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER LYS SEQRES 15 A 265 PHE SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL LEU SEQRES 16 A 265 MET TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR GLU SEQRES 17 A 265 ARG PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA GLN SEQRES 18 A 265 GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU LYS SEQRES 19 A 265 VAL TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS ALA SEQRES 20 A 265 ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN ILE SEQRES 21 A 265 LEU ASP VAL MET ASP HET 1N1 A 663 41 HETNAM 1N1 N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL) HETNAM 2 1N1 PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3- HETNAM 3 1N1 THIAZOLE-5-CARBOXAMIDE HETSYN 1N1 DASATINIB FORMUL 2 1N1 C22 H26 CL N7 O2 S FORMUL 3 HOH *101(H2 O) HELIX 1 1 ASP A 398 LYS A 400 5 3 HELIX 2 2 SER A 438 ASN A 451 1 14 HELIX 3 3 CYS A 481 MET A 489 1 9 HELIX 4 4 GLN A 494 LYS A 515 1 22 HELIX 5 5 ALA A 523 ARG A 525 5 3 HELIX 6 6 PRO A 560 SER A 564 5 5 HELIX 7 7 PRO A 565 SER A 572 1 8 HELIX 8 8 SER A 575 SER A 592 1 18 HELIX 9 9 THR A 602 GLN A 612 1 11 HELIX 10 10 SER A 623 CYS A 633 1 11 HELIX 11 11 LYS A 637 ARG A 641 5 5 HELIX 12 12 THR A 643 ASP A 656 1 14 SHEET 1 A 5 LEU A 402 GLU A 407 0 SHEET 2 A 5 VAL A 415 TRP A 421 -1 O TYR A 418 N LYS A 406 SHEET 3 A 5 TYR A 425 MET A 431 -1 O ILE A 429 N LYS A 417 SHEET 4 A 5 PHE A 471 GLU A 475 -1 O ILE A 472 N LYS A 430 SHEET 5 A 5 LEU A 460 CYS A 464 -1 N TYR A 461 O ILE A 473 SHEET 1 B 2 CYS A 527 VAL A 529 0 SHEET 2 B 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 CISPEP 1 ARG A 468 PRO A 469 0 4.41 SITE 1 AC1 15 ALA A 428 LYS A 430 MET A 449 ILE A 472 SITE 2 AC1 15 THR A 474 GLU A 475 TYR A 476 MET A 477 SITE 3 AC1 15 ALA A 478 ASN A 479 GLY A 480 GLU A 488 SITE 4 AC1 15 LEU A 528 SER A 538 PHE A 540 CRYST1 54.101 42.944 64.542 90.00 112.58 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018484 0.000000 0.007687 0.00000 SCALE2 0.000000 0.023286 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016780 0.00000